The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...

In a statement, FDA Chief AI Officer Jeremy Walsh trumpeted the rollout, saying: "Today marks the dawn of the AI era at the FDA[. W]ith the release of Elsa, AI is no longer a distant promise but a ...

In Tuesday’s announcement, FDA Chief AI Officer Jeremy Walsh said, “Today marks the dawn of the AI era at the FDA with the release of Elsa, AI is no longer a distant promise but a dynamic ...

The FDA plans to roll out its new AI tool, called Elsa, “ahead of schedule and under budget,” according to Commissioner Dr. Marty Makary, who offered up the most information to date about the ...

“As the tool matures, the agency has plans to integrate more AI in different processes, such as data processing and generative-AI functions to further support the FDA’s mission.” Elsa’s ...

The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices. In a remarkable pilot, ELSA has proven to significantly reduce the time ...

The U.S. Food and Drug Administration (FDA) has launched Elsa, an AI tool designed to modernize and speed up agency-wide operations ranging from scientific reviews to investigations. Marty Makary ...

The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets. FDA launches AI tool Elsa | Drug ...

The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency from unveiling a new generative AI tool a month ahead of schedule ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. The FDA plans to roll out its new AI tool, called Elsa ...